Tica Doctor Collaborates in Research on Nanoantibodies as Treatment Against COVID-19

    Must Read

    Like you, we are tired of corporate media that is politically driven and one sided. So we decided to focus on news that’s important to people. We’re Creating a Conscious alternative news network that we feel the world needs and we need your help! We can’t do this without you! Support news and media that matters and that can help change our world!

    Zaray Miranda is a young Costa Rican doctor who is contributing to a research at the Austral University of Chile that proposes the use of nanoantibodies from Chilean alpacas as a low-cost treatment for patients with COVID-19. The procedure was announced by the scientific journal Scientific Reports, of the British publishing group Nature.

    Doctor Miranda, who is a graduate of the University of Costa Rica, helped to achieve this scientific achievement that today is positioned in the international arena as a fast, cheap and simple method aimed at selecting the nanoantibodies with the greatest capacity to neutralize the virus.

    TIP: Get our latest content by joining our newsletter. Don't miss out on news that matter in Costa Rica. Click here.

    Viable treatment against COVID-19

    “The important thing here is that we innovate in the selection of nanoantibodies with a low-cost method. At present, isolating specific antibodies against the protein that allows COVID-19 to enter the human cell may be essential in the development of effective diagnostic and therapeutic tools. For this reason, we wanted to contribute and share this knowledge with the international scientific community”, said Miranda in an interview with her alma mater.


    To achieve this, scientists worked for more than a year with the obligation to verify the neutralization power of alpaca nanoantibodies that actually inhibited the infectious capacity of COVID-19. The results obtained by the team are so encouraging, that the researchers have already advanced to another little-explored level: linking the nanoantibody of these animals with the human antibody.

    The idea is to soon translate this innovation into the generation of injectable immunotherapy, which serves to reduce the severity of the disease in patients diagnosed early and who have a high probability of dying from their underlying pathologies.

    LIKE THIS ARTICLE? Sign up to our newsletter and we will send you updates of our latest content as soon as they are available. Click here.

    - Advertisement -
    - Advertisement -

    Latest News

    Avianca Announces New Flights from San José to Washington D.C.

    The Avianca Group announced a new flight starting July 15th, operated by its Costa Rican subsidiary, between the cities...
    - Advertisement -

    More Articles Like This

    - Advertisement -
    Language »

    Get TCRN In Your Inbox & Never Miss Any News That Matter In Costa Rica!